Illumina, Inc. vs Manulife Financial Corporation — how do they compare? Illumina, Inc. trades at $189.82 (market cap $27.94B), while Manulife Financial Corporation trades at $42.77 (market cap $69.96B). The key difference: Manulife Financial Corporation is far larger — about 2.5× Illumina, Inc.'s market cap, and Manulife Financial Corporation pays a 3.14% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | MFC | |
|---|---|---|
Market Cap | $27.94B | $69.96B |
Sector | Health | Financials |
52-Week High | $194.33 | $43.39 |
52-Week Low | $91.00 | $29.90 |
Enterprise Value | $29.33B | $66.52B |
Dividend Yield | — | 3.14% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Manulife Financial (MFC) trades at $42.56, down 1.91% today but remains near 52-week highs. The stock shows strong fundamentals with revenue growth from $46.2B in 2024 to $53.0B in 2025 and consistent profitability (12.07% net margin). Technical indicators are mixed with bullish moving averages but overbought RSI levels. Recent Q1 2026 earnings missed expectations despite strong Asia performance, while analyst consensus remains bullish with 57% buy ratings.
MFC presents a compelling value case with reasonable valuation (P/E 17.75) and dividend yield support. Key opportunities include AI integration partnerships and Asia growth, though risks include wealth management outflows and regulatory scrutiny. The stock's current technical overbought condition suggests potential near-term consolidation before resuming upward trajectory.
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →